Leukemia
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human CD5 (Clone UCHT-2) - FITC - 200 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - FITC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - PE - 50 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - PE - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - PE - 100 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - PE - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - PE - 200 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - PE - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - Purified - 50 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - Purified - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - Purified - 100 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - Purified - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - Purified - 200 µg | Anmelden | Anti-Human CD5 (Clone UCHT-2) - Purified - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human MyD88 (CT) - 0.1 mg | Anmelden | Anti-Human MyD88 (CT) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human MyD88 (Intermediate Domain) - 0.1 mg | Anmelden | Anti-Human MyD88 (Intermediate Domain) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] - 1.0 mg | Anmelden | Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] - 25 mg | Anmelden | Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] - 25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] – Biotin - 100 µg | Anmelden | Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] – Biotin - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] – Fc Muted™ Biotin - 100 µg | Anmelden | Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] – Fc Muted™ Biotin - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] – Fc Muted™ HRP - 100 µg | Anmelden | Anti-Human CD194 (CCR4) Mogamulizumab [Clone KW-0761] – Fc Muted™ HRP - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] - 1.0 mg | Anmelden | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] - 50 mg | Anmelden | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] - 50 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] - 100 mg | Anmelden | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] - 100 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] – PE - 50 µg | Anmelden | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) [Hu114] – PE - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Fc Muted™ - 500 µg | Anmelden | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||


